DimbergLab

We are studying the tumor microenvironment to understand cancer progression and response to therapy. Our goal is to find new ways to treat cancer.

[DimbergLab @DimbergLab]

So exciting to see our PI Anna Dimberg’s
talk being featured as part of the most noteworthy highlights of #CIMT2024, the biggest cancer immunotherapy conference in Europe! 🤩 See the article here https://t.co/T5FZgY0qf6

[Katharina Imkeller @K_Imkeller]

Our preprint on tertiary lymphoid structures in human brain tumors is online! Joint work with colleagues from @FCI_health @goetheuni Edinger Institute. https://t.co/U6QLzCGr3n

[DimbergLab @DimbergLab]

Want to sit back, relax and enjoy? Find also a short AI-generated audio summary of our paper here🤖 https://t.co/Xo1dUdhZbp

[DimbergLab @DimbergLab]

What if we knew more about the 𝒅𝒆𝒗𝒆𝒍𝒐𝒑𝒎𝒆𝒏𝒕 𝒐𝒇 𝒕𝒆𝒓𝒕𝒊𝒂𝒓𝒚 𝒍𝒚𝒎𝒑𝒉𝒐𝒊𝒅 𝒔𝒕𝒓𝒖𝒄𝒕𝒖𝒓𝒆𝒔 (TLS) in 𝒄𝒂𝒏𝒄𝒆𝒓, to produce TLS-inducing therapies that can 𝒉𝒆𝒍𝒑 𝒑𝒂𝒕𝒊𝒆𝒏𝒕𝒔? 💉 Look no further than this thread! ⭐️
https://t.co/MQngiwABLb

[DimbergLab @DimbergLab]

Extra curious?🧐 Have a look at our paper to find out more about the interplay between 𝑪𝑫4 𝑻 𝒄𝒆𝒍𝒍𝒔, 𝒇𝒊𝒃𝒓𝒐𝒃𝒍𝒂𝒔𝒕𝒔, 𝒎𝒚𝒆𝒍𝒐𝒊𝒅 𝒄𝒆𝒍𝒍𝒔 and 𝒄𝒐𝒍𝒍𝒂𝒈𝒆𝒏 𝒓𝒆-𝒂𝒓𝒓𝒂𝒏𝒈𝒆𝒎𝒆𝒏𝒕 during the assembly of TLS in GBM!

[DimbergLab @DimbergLab]

Vårt projekt om hur blodkärlen påverkar hur hjärntumörer växer och svarar på terapi var ett av de 224 som fick anslag från @Cancerfonden! Tack alla som skänker gåvor till forskningen och gör detta möjligt! #tillsammansmotcancer #cancerfonden

https://t.co/J4gpWjxuQ9

[DimbergLab @DimbergLab]

📢 𝐑𝐞𝐯𝐢𝐞𝐰 𝐚𝐥𝐞𝐫𝐭! How much do we really know about 𝐭𝐞𝐫𝐭𝐢𝐚𝐫𝐲 𝐥𝐲𝐦𝐩𝐡𝐨𝐢𝐝 ���𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐞𝐬 in cancer?🧐Here we review how studies in murine models have furthered our understanding of TLS biology🐭. https://t.co/8CGSvauKNM

[Cancer Cell @Cancer_Cell]

Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma https://t.co/8C7s7dljz5

[Cancer Discovery @CD_AACR]

Read this week's #ResearchWatch:
AAV-Mediated Gene Delivery of LIGHT Prolongs Survival in #Glioblastoma, summarizing the work of @mohanraj9706, @AleVaccaro93, @tiarnevdw, Magnus Essand, @DimbergLab et al.
https://t.co/2sWuE7hMQa
@UU_University

[Mohan @mohanraj9706]

Our recent work on AAV-mediated #Immunotherapy for #Glioblastoma is highlighted by @CD_AACR.

[Cancer Cell @Cancer_Cell]

Online Now: Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma https://t.co/7E5OuP0Bf6

[DimbergLab @DimbergLab]

Congratulations to @mohanraj9706 , @AleVaccaro93 , @tiarnevdw and the rest of the team! It is finally out!!

[DimbergLab @DimbergLab]

Curious on how we modified blood vessels to boost immunity and treat brain cancer? 💉🧠 Our new publication is out now on @Cancer_Cell ! Big congrats to the first authors of this work, @mohanraj9706 , @AleVaccaro93 & @tiarnevdw , and to the whole team 🥳 https://t.co/KRgJq3Lo2R

[DimbergLab @DimbergLab]

Curious on how we modified blood vessels to boost immunity and treat brain cancer? 💉🧠 Our new publication is out now on @Cancer_Cell ! Big congrats to the first authors of this work, @mohanraj9706 , @AleVaccaro93 & @tiarnevdw , and to the whole team 🥳 https://t.co/KRgJq3Lo2R

[DimbergLab @DimbergLab]

Huge congrats to our PhD student @tiarnevdw, who won the judge’s “Best Talk” price at the 4th STorM retreat! @STorMSciLifeLab 🎉🏆 Way to go!

[KPietraslab @KPietraslab]

So excited for the next few days at the STorM retreat @STorMSciLifeLab and for meeting the Swedish microenvironment community IRL🤩 Big thanks to @kalyani05v @Milena_kp @JessicaPantal13 and Favour Onyeogaziri for putting together a fantastic program